John McCoy
President at CARDIOVASCULAR SYSTEMS, INC.
Net worth: 2 M $ as of 2024-04-29
John McCoy active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | President | - | - |
| Treasurer | - | - | |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 2023-08-31 | - |
| Corporate Officer/Principal | 2017-12-31 | 2020-12-31 | |
| Treasurer | 2020-12-31 | 2023-08-31 |
Career history of John McCoy
Former positions of John McCoy
| Companies | Position | Start | End |
|---|---|---|---|
| BAXALTA INC | Comptroller/Controller/Auditor | 2015-05-31 | 2015-12-31 |
Statistics
International
| United States | 4 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| President | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private companies | 2 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Cardiovascular Systems, Inc.
 Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |
- Stock Market
- Insiders
- John McCoy
- Experience
